TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,845,003 | +11.6% | 4,062,379 | +13.3% | 0.03% | +10.7% |
| Q2 2023 | $56,322,958 | +78648.0% | 3,585,166 | -17.4% | 0.03% | -31.7% |
| Q1 2023 | $71,523 | +104.8% | 4,339,982 | +93.9% | 0.04% | +115.8% |
| Q4 2022 | $34,919 | -99.7% | 2,238,381 | +124.1% | 0.02% | +137.5% |
| Q3 2022 | $12,957,000 | -25.8% | 998,999 | -19.7% | 0.01% | -27.3% |
| Q2 2022 | $17,458,000 | +80.3% | 1,243,422 | +83.9% | 0.01% | +120.0% |
| Q1 2022 | $9,682,000 | +1484.6% | 676,131 | +1407.5% | 0.01% | – |
| Q4 2021 | $611,000 | +137.7% | 44,851 | +186.2% | 0.00% | – |
| Q3 2021 | $257,000 | -93.8% | 15,669 | -93.6% | 0.00% | -100.0% |
| Q2 2021 | $4,139,000 | -31.0% | 245,912 | -25.1% | 0.00% | -25.0% |
| Q1 2021 | $5,997,000 | -34.8% | 328,449 | -36.3% | 0.00% | -63.6% |
| Q3 2020 | $9,195,000 | -41.3% | 515,404 | -41.0% | 0.01% | -47.6% |
| Q2 2020 | $15,669,000 | +13.4% | 873,923 | -4.0% | 0.02% | -32.3% |
| Q1 2020 | $13,817,000 | +107.6% | 910,211 | +169.9% | 0.03% | +287.5% |
| Q4 2019 | $6,654,000 | +100.5% | 337,271 | +79.9% | 0.01% | +60.0% |
| Q2 2019 | $3,319,000 | -91.6% | 187,487 | -90.3% | 0.01% | -91.5% |
| Q1 2019 | $39,502,000 | +18273.0% | 1,939,209 | +15050.1% | 0.06% | – |
| Q4 2018 | $215,000 | – | 12,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |